# InvestorNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Completes Acquisition of Bio Legacy Evaluative Group, Expanding into Biotech and Medical Devices

Branded Legacy (OTC: BLEG), a diversified holdings company in the health and wellness sector, has completed its acquisition of Bio Legacy Evaluative Group, formerly Menlo Health, in an all-stock deal valued at $1.5 million in Preferred D shares. The transaction, closed July 31, 2025, positions Branded Legacy to address global health challenges such as the addiction epidemic and vaccine distribution inefficiencies. Under CEO Amin Janmohamed, Bio Legacy brings a patented all-in-one intranasal naloxone device targeting a market projected to grow from $371 million in 2022 to over $1.16 billion by 2032, along with technology for nasal delivery of vaccines and cold-chain therapies. The acquisition includes performance-based conversion milestones, a two-year lock-up, and a $1 million R&D commitment post-uplisting to OTCQB.

 To view the full press release, visit https://ibn.fm/U7eSy

 About Branded Legacy Inc.

 Branded Legacy is a forward-thinking company specializing in the development and commercialization of biotech and wellness products. With a focus on strategic growth, innovation and quality, the company is dedicated to enhancing lives and creating sustainable value for its shareholders.

 For more information, visit the company’s website at https://BrandedLegacy.com.

 About InvestorWire

 InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

 For more information, please visit https://www.InvestorWire.com

 Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

 InvestorWireAustin, Texaswww.InvestorWire.com512.354.7000 OfficeEditor@InvestorWire.com

 InvestorWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/iw/investornewsbreaks-branded-legacy-inc-otc-bleg-completes-acquisition-of-bio-legacy-evaluative-group-expanding-into-biotech-and-medical-devices/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/branded-legacy-acquires-bio-legacy-to-combat-global-health-challenges/3b180a80cdf846e52173cc62b7fb767e) 

 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1modvr0/branded_legacy_acquires_bio_legacy_to_combat/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/258/12/goldOvbk.webp)